CA125

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
M. J. DUFFY, J. M. BONFRER, J. KULPA, G. J.S. RUSTIN, G. SOLETORMOS, G. C. TORRE, M. K. TUXEN, M. ZWIRNER

International Journal of Gynecologic Cancer Sep 2005, 15 (5) 679-691; DOI: 10.1136/ijgc-00009577-200509000-00001
Investigation of women with endometrial carcinoma using serum vascular endothelial growth factor (VEGF) measurement
R. J. Gornall, F. W. Anthony, E. J. Coombes, P. Hogston, R. P. Woolas

International Journal of Gynecologic Cancer Mar 2001, 11 (2) 164-166; DOI: 10.1136/ijgc-00009577-200103000-00011
Using Serum CA125 to Assess the Activity of Potential Cytostatic Agents in Ovarian Cancer
Marcia R. Hall, Ann Petruckevitch, Joanna Pascoe, Mojca Persic, Saad Tahir, Jamie S. Morgan, Charlie Gourley, Nick Stuart, S. Michael Crawford, Diana E. Kornbrot, Wendi Qian, Gordon J. Rustin

International Journal of Gynecologic Cancer May 2014, 24 (4) 676-681; DOI: 10.1097/IGC.0000000000000116
Struma ovarii showing clinical characteristics of ovarian malignancy
S. Y. RIM, S. M. KIM, H. S. CHOI

International Journal of Gynecologic Cancer Nov 2005, 15 (6) 1156-1159; DOI: 10.1136/ijgc-00009577-200511000-00027
CA19-9 may have clinical significance in mature cystic teratomas of the ovary
M. Dede, S. Gungor, M. C. Yenen, I. Alanbay, N. K. Duru, A. HaŞImi

International Journal of Gynecologic Cancer Jan 2006, 16 (1) 189-193; DOI: 10.1136/ijgc-00009577-200601000-00031
CA125 parameters in survivors and non-survivors with epithelial ovarian cancer
D. J. CRUICKSHANK

International Journal of Gynecologic Cancer Oct 1991, 1 (6) 279-284; DOI: 10.1111/j.1525-1438.1991.tb00056.x
Serous and mucinous borderline tumors of the ovary: a clinicopathologic and DNA-ploidy study of 102 cases
T. Kuoppala, M. Heinola, R. Aine, J. Isola, P.K. Heinonen

International Journal of Gynecologic Cancer Jul 1996, 6 (4) 302-308; DOI: 10.1136/ijgc-00009577-199607000-00010
Neoadjuvant chemotherapy for advanced ovarian cancer
E. Surwit, J. Childers, I. Atlas, M. Nour, K. Hatch, A. Hallum, D. Alberts

International Journal of Gynecologic Cancer Sep 1996, 6 (5) 356-361; DOI: 10.1136/ijgc-00009577-199609000-00002
For stage III epithelial ovarian cancer the initial level of expression of CA125 does not correlate with survival in women who respond to treatment
J.A. Latimer, C. G. Beng, M. L.J. Davy

International Journal of Gynecologic Cancer Sep 1996, 6 (5) 380-384; DOI: 10.1136/ijgc-00009577-199609000-00006
Influence of 2-(¹⁸F) Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography on Recurrent Ovarian Cancer Diagnosis and on Selection of Patients for Secondary Cytoreductive Surgery
Signe Risum, Claus Høgdall, Elena Markova, Anne K. Berthelsen, Annika Loft, Flemming Jensen, Estrid Høgdall, Henrik Roed, Svend A. Engelholm

International Journal of Gynecologic Cancer Apr 2009, 19 (4) 600-604; DOI: 10.1111/IGC.0b013e3181a3cc94

Main menu

CA125

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CA125

Pages